For example, the EZH2, KDM1A, KANSL1, KDM6B, and KAT8 genes are upregulated in lung cancer patients, while EP300, MECP2, and SETD2 are downregulated in lung cancer (Figure 2C). This evidence concerns the gene SETD2 and lung carcinoma.